Support The Show On Patreon!:
https://www.patreon.com/seculartalk

Subscribe to Krystal Kyle & Friends On Substack!:
https://krystalkyleandfriends.substack.com

Vancouver-based MYND Life Sciences is exploring whether depression and other central nervous system disorders can be treated with novel psychedelic drugs, including psilocybin.

In January, the company announced a collaborative research agreement with the University of British Columbia on major depressive disorder.

https://www.thegrowthop.com/cannabis-news/psychedelics/this-canadian-psychedelic-drug-company-is-working-on-a-vaccine-for-depression

https://www.axios.com/states-fund-psychedelic-research-mental-health-ec6a4b6b-62fd-4ff0-aecf-38d07cf00d65.html

Follow Kyle on Twitter:

#KyleKulinski #SecularTalk